K. Takeda, et.al., Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency., The Journal of endocrinology, 2003, 176

http://rdf.ncbi.nlm.nih.gov/pubmed/12553872

K. Takeda, et.al., Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency., The Journal of endocrinology, 2003, 176

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating triglyceride level_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0001552I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased body weight_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0001260I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• obese_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0001261I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased gonadal fat pad weight_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0009285I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased susceptibility to weight gain_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0005455I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased circulating glucose level_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0005559I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased abdominal fat pad weight_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0009286I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• hepatic steatosis_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0002628I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• impaired glucose tolerance_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0005293I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased renal fat pad weight_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0009302I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased circulating cholesterol level_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0005178I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• insulin resistance_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0005331I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda
• increased circulating testosterone level_Cyp19a1<tm1Toda>/Cyp19a1<tm1Toda>
  http://metadb.riken.jp/0002781I129P2OlaHsdC57BL6JCyp19a1tm1TodaCyp19a1tm1TodaCyp19a1tm1Toda